Pulse Biosciences, Inc. (PLSE)
Market: NASD |
Currency: USD
Address: 3957 Point Eden Way
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
📈 Pulse Biosciences, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Pulse Biosciences, Inc.
Date | Reported EPS |
---|
2026-05-06 (estimated upcoming) | - |
2026-03-25 (estimated upcoming) | - |
2025-10-28 (estimated upcoming) | - |
2025-08-11 (estimated upcoming) | - |
2025-05-08 | - |
2025-03-27 | - |
2024-10-30 | - |
2024-08-19 | - |
2024-05-07 | - |
2024-03-28 | - |
2023-11-13 | - |
2023-08-10 | -0.22 |
2023-05-11 | -0.26 |
2023-03-30 | -0.25 |
2022-11-10 | -0.49 |
2022-08-10 | -0.44 |
2022-05-11 | -0.58 |
2022-03-31 | -0.52 |
2021-11-15 | -0.48 |
2021-08-09 | -0.58 |
2021-05-10 | -0.71 |
2021-02-22 | -0.54 |
2020-11-09 | -0.51 |
2020-08-10 | -0.53 |
2020-05-11 | -0.57 |
2020-03-16 | -0.66 |
📰 Related News & Research
No related articles found for "pulse biosciences".